BOSTON — Makers of remote cardiology monitoring systems received a dose of good news with the announcement by the Heart Rhythm Society (HRS; Washington) that remote monitoring should be the standard of care for patients with device implants. The news is another in a series of positives for the device category, given that recent estimates of the market for remote monitoring and cardiac rhythm management systems are expected to jointly reach more than $23 billion in 2017.